Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...
In a 12-week randomized trial, replacing refined wheat with wholegrain rye in a calorie-restricted diet did not produce ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
While a randomized controlled trial of vitamin D 3 supplementation in COVID-19 patients didn’t yield a significant reduction ...
As reported by the Twin Cities Business Journal, the $50 million infusion was announced March 25 and will be used to move the ReCET system further into the trial phase. The Business Journal identified ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...
Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results